# Use of Indocyanine Green in Acute Cholecystitis

> **NCT05709548** · PHASE4 · UNKNOWN · sponsor: **Corporacion Parc Tauli** · enrollment: 440 (estimated)

## Conditions studied

- Acute Cholecystitis
- Bile Duct Injury

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT05709548
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-15
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709548, "Use of Indocyanine Green in Acute Cholecystitis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05709548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*